The utilization of fluorescein in brain tumor surgery: A systematic review

Claudio Cavallo, Camilla De Laurentis, Ignazio G. Vetrano, Jacopo Falco, Morgan Broggi, Marco Schiariti, Paolo Ferroli, Francesco Acerbi

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

INTRODUCTION: Sodium fluorescein (SF) is a green, water-soluble dye with the capacity to accumulate in cerebral areas as a result of damaged blood-brain barrier (BBB); this property allows SF to concentrate specifically at the tumor site of various types of brain neoplasms, making the tumor tissue more clearly visible. EVIDENCE ACQUISITION: A literature search (1947-2018) was conducted with the keywords "fluorescein neurosurgery," "YELLOW neurosurgery," "fluorescein brain tumor," "YELLOW brain tumor." We included clinical studies, clinical trials, observational studies, only conducted on humans and concerning surgery; in addition, we have included 3 articles derived from the analysis of the references of other papers. Ultimately, 57 articles were included for further analysis. EVIDENCE SYNTHESIS: Fluorescein as a fluorescent tracer in neuro-oncology is gaining a wider acceptance in the neurosurgical literature: until February 1st, 2018, at least 1099 neuro-oncological patients have been operated through fluorescein-assistance, mostly only after 2012. The most important application remains the aim to improve tumor visualization and extent of resection for high-grade gliomas (HGG), but the nonspecific mechanism of action is the theoretical base for its use also for tumors different from HGG. Nevertheless, no homogenous protocol of fluorescein utilization in neurosurgical oncology can be found in literature. CONCLUSIONS: Fluorescein-guided surgery is a safe and effective technique to improve visualization and resection of different CNS tumors and conditions, based on BBB alteration, with a growing evidence-based background.

Original languageEnglish
Pages (from-to)690-703
Number of pages14
JournalJournal of Neurosurgical Sciences
Volume62
Issue number6
DOIs
Publication statusPublished - Dec 1 2018

Fingerprint

Fluorescein
Brain Neoplasms
Neurosurgery
Neoplasms
Blood-Brain Barrier
Glioma
Observational Studies
Coloring Agents
Clinical Trials
Water

Keywords

  • Central nervous system neoplasms
  • Fluorescein
  • Surgery

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

The utilization of fluorescein in brain tumor surgery : A systematic review. / Cavallo, Claudio; De Laurentis, Camilla; Vetrano, Ignazio G.; Falco, Jacopo; Broggi, Morgan; Schiariti, Marco; Ferroli, Paolo; Acerbi, Francesco.

In: Journal of Neurosurgical Sciences, Vol. 62, No. 6, 01.12.2018, p. 690-703.

Research output: Contribution to journalReview article

Cavallo, Claudio ; De Laurentis, Camilla ; Vetrano, Ignazio G. ; Falco, Jacopo ; Broggi, Morgan ; Schiariti, Marco ; Ferroli, Paolo ; Acerbi, Francesco. / The utilization of fluorescein in brain tumor surgery : A systematic review. In: Journal of Neurosurgical Sciences. 2018 ; Vol. 62, No. 6. pp. 690-703.
@article{0b867222e66844b98004476e8e920198,
title = "The utilization of fluorescein in brain tumor surgery: A systematic review",
abstract = "INTRODUCTION: Sodium fluorescein (SF) is a green, water-soluble dye with the capacity to accumulate in cerebral areas as a result of damaged blood-brain barrier (BBB); this property allows SF to concentrate specifically at the tumor site of various types of brain neoplasms, making the tumor tissue more clearly visible. EVIDENCE ACQUISITION: A literature search (1947-2018) was conducted with the keywords {"}fluorescein neurosurgery,{"} {"}YELLOW neurosurgery,{"} {"}fluorescein brain tumor,{"} {"}YELLOW brain tumor.{"} We included clinical studies, clinical trials, observational studies, only conducted on humans and concerning surgery; in addition, we have included 3 articles derived from the analysis of the references of other papers. Ultimately, 57 articles were included for further analysis. EVIDENCE SYNTHESIS: Fluorescein as a fluorescent tracer in neuro-oncology is gaining a wider acceptance in the neurosurgical literature: until February 1st, 2018, at least 1099 neuro-oncological patients have been operated through fluorescein-assistance, mostly only after 2012. The most important application remains the aim to improve tumor visualization and extent of resection for high-grade gliomas (HGG), but the nonspecific mechanism of action is the theoretical base for its use also for tumors different from HGG. Nevertheless, no homogenous protocol of fluorescein utilization in neurosurgical oncology can be found in literature. CONCLUSIONS: Fluorescein-guided surgery is a safe and effective technique to improve visualization and resection of different CNS tumors and conditions, based on BBB alteration, with a growing evidence-based background.",
keywords = "Central nervous system neoplasms, Fluorescein, Surgery",
author = "Claudio Cavallo and {De Laurentis}, Camilla and Vetrano, {Ignazio G.} and Jacopo Falco and Morgan Broggi and Marco Schiariti and Paolo Ferroli and Francesco Acerbi",
year = "2018",
month = "12",
day = "1",
doi = "10.23736/S0390-5616.18.04480-6",
language = "English",
volume = "62",
pages = "690--703",
journal = "Journal of Neurosurgical Sciences",
issn = "0026-4881",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "6",

}

TY - JOUR

T1 - The utilization of fluorescein in brain tumor surgery

T2 - A systematic review

AU - Cavallo, Claudio

AU - De Laurentis, Camilla

AU - Vetrano, Ignazio G.

AU - Falco, Jacopo

AU - Broggi, Morgan

AU - Schiariti, Marco

AU - Ferroli, Paolo

AU - Acerbi, Francesco

PY - 2018/12/1

Y1 - 2018/12/1

N2 - INTRODUCTION: Sodium fluorescein (SF) is a green, water-soluble dye with the capacity to accumulate in cerebral areas as a result of damaged blood-brain barrier (BBB); this property allows SF to concentrate specifically at the tumor site of various types of brain neoplasms, making the tumor tissue more clearly visible. EVIDENCE ACQUISITION: A literature search (1947-2018) was conducted with the keywords "fluorescein neurosurgery," "YELLOW neurosurgery," "fluorescein brain tumor," "YELLOW brain tumor." We included clinical studies, clinical trials, observational studies, only conducted on humans and concerning surgery; in addition, we have included 3 articles derived from the analysis of the references of other papers. Ultimately, 57 articles were included for further analysis. EVIDENCE SYNTHESIS: Fluorescein as a fluorescent tracer in neuro-oncology is gaining a wider acceptance in the neurosurgical literature: until February 1st, 2018, at least 1099 neuro-oncological patients have been operated through fluorescein-assistance, mostly only after 2012. The most important application remains the aim to improve tumor visualization and extent of resection for high-grade gliomas (HGG), but the nonspecific mechanism of action is the theoretical base for its use also for tumors different from HGG. Nevertheless, no homogenous protocol of fluorescein utilization in neurosurgical oncology can be found in literature. CONCLUSIONS: Fluorescein-guided surgery is a safe and effective technique to improve visualization and resection of different CNS tumors and conditions, based on BBB alteration, with a growing evidence-based background.

AB - INTRODUCTION: Sodium fluorescein (SF) is a green, water-soluble dye with the capacity to accumulate in cerebral areas as a result of damaged blood-brain barrier (BBB); this property allows SF to concentrate specifically at the tumor site of various types of brain neoplasms, making the tumor tissue more clearly visible. EVIDENCE ACQUISITION: A literature search (1947-2018) was conducted with the keywords "fluorescein neurosurgery," "YELLOW neurosurgery," "fluorescein brain tumor," "YELLOW brain tumor." We included clinical studies, clinical trials, observational studies, only conducted on humans and concerning surgery; in addition, we have included 3 articles derived from the analysis of the references of other papers. Ultimately, 57 articles were included for further analysis. EVIDENCE SYNTHESIS: Fluorescein as a fluorescent tracer in neuro-oncology is gaining a wider acceptance in the neurosurgical literature: until February 1st, 2018, at least 1099 neuro-oncological patients have been operated through fluorescein-assistance, mostly only after 2012. The most important application remains the aim to improve tumor visualization and extent of resection for high-grade gliomas (HGG), but the nonspecific mechanism of action is the theoretical base for its use also for tumors different from HGG. Nevertheless, no homogenous protocol of fluorescein utilization in neurosurgical oncology can be found in literature. CONCLUSIONS: Fluorescein-guided surgery is a safe and effective technique to improve visualization and resection of different CNS tumors and conditions, based on BBB alteration, with a growing evidence-based background.

KW - Central nervous system neoplasms

KW - Fluorescein

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=85058489495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058489495&partnerID=8YFLogxK

U2 - 10.23736/S0390-5616.18.04480-6

DO - 10.23736/S0390-5616.18.04480-6

M3 - Review article

C2 - 29790725

AN - SCOPUS:85058489495

VL - 62

SP - 690

EP - 703

JO - Journal of Neurosurgical Sciences

JF - Journal of Neurosurgical Sciences

SN - 0026-4881

IS - 6

ER -